April 18, 2025 — Eric Maus
This Week in Waste highlights how taxpayer dollars are being wasted and efforts to fight back against this waste.
April 18, 2025 — Eric Maus 1745007259
April 16, 2025 — Thomas Schatz
President Trump's EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP
April 16, 2025 — Thomas Schatz 1744839152
HB 1150 would lead to the loss of more than 135 brick and mortar retail pharmacies in the state and eliminate associated cost-saving mail order and specialty pharmacy options.
HB 1724 would impose price controls on prescription drugs.
SB 45, SB 372, and SB 512 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy benefit managers in Missouri and increase prescription drug costs for patients.
HB 474 and HB 840 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy benefit managers in Missouri and increase prescription drug costs for patients.
HB 1150 would lead to closing more than 135 brick and mortar retail pharmacies in Arkansas, eliminating cost-saving mail order and specialty pharmacy options for employers.
SB 1179 will change how the federal 340B Drug Pricing Program operates in Michigan.